MedPath

Partners in Care Diabetes Self-management Intervention

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Behavioral: Partners in Care
Registration Number
NCT01235429
Lead Sponsor
University of Hawaii
Brief Summary

Type 2 diabetes is common among Native Hawaiians and Pacific Peoples. Diabetes related complications decrease quality of life and can result in early morbidity. The purpose of the Partners in Care diabetes self-management educational intervention is to teach participants how to manage their diabetes to avoid or delay diabetes-related complications and how to better work with their health care team.

Detailed Description

This is a feasibility study using a randomized controlled trial (RCT) design in which 100 Native Hawaiians (NHs) and other Pacific Islanders (PPs) will be randomized to either a 3-month diabetes self-management group (DSMG; N=50) or a delayed intervention control group (CG; N=50). Participants in the DSMG will receive culturally-tailored, group diabetes self-management education delivered in a community setting by trained community peer educators. To meet this objective, we have partnered with four community-based organizations: 1) Hawai'i Maoli Association of Hawaiian Civic Clubs, 2) Ke Ola Mamo Native Hawaiian Health Care System, 3) Kokua Kalihi Valley Comprehensive Family Services, and 4) Kula No Nā Po'e Hawai'i. These four organizations provide services to a large number of Pacific People to include, but not limited to, Native Hawaiians, Samoans, Filipinos, and Chuukese. They already have intervention research experience as members of the PILI 'Ohana CBPR Project. The 3-month face-to-face intervention will be community-based and community-led by trained community peer educators from these four partnering community organizations. Individuals with a hemoglobin A1c (HbA1c; average blood sugar levels) \>=8% will be recruited for the study because they represent the most at-risk for diabetes-related complications.

Over a 1-year accrual period, the community partners will recruit and enroll 100 eligible NHs and PPs (25 participants per a participating community), as well as deliver and evaluate the intervention in their respective community settings. The primary outcomes of our study are hemoglobin A1c and self-reported diabetes specific quality of life. Secondary outcomes are cholesterol levels (including HDL, LDL, total cholesterol, and triglycerides), blood pressure, body mass index, and psychosocial adaptation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Self-reported Native Hawaiian, Filipino, or other Pacific Islander ethnic background,
  2. Adults age >=18 years,
  3. English-speaking,
  4. Physician-diagnosed type 2 diabetes, and
  5. Baseline hemoglobin A1c >=8%
Exclusion Criteria
  1. Survival less than 6 months,
  2. Planning to move off island or out of state during the study period,
  3. Pregnancy,
  4. Any co-morbid condition (physical and mental disabilities) that would prevent the individual from participating in the intervention protocol (i.e., major psychiatric illness).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
EducationalPartners in CareParticipants will receive 12 diabetes self-management educational lessons in a small group setting located within the participating communities and delivered by trained community health workers.
Delayed educationPartners in CareThe delayed education group will receive the same intervention after the intervention group has completed the educational lessons and all participants have completed the follow-up assessments.
Primary Outcome Measures
NameTimeMethod
hemoglobin A1c3 months

Hemoglobin A1c will be assessed at baseline and post intervention in the intervention and delayed intervention participants.

Secondary Outcome Measures
NameTimeMethod
Quality of life3 months

Quality of life using the Problem Areas in Diabetes survey will be assessed at baseline and post intervention in the intervention and delayed intervention participants.

Trial Locations

Locations (1)

University of Hawaii

🇺🇸

Honolulu, Hawaii, United States

© Copyright 2025. All Rights Reserved by MedPath